Niels Riedemann
Company: Inflarx
Job title: CEO
Seminars:
The Oral C5aR Inhibitor INF904 for the Treatment of Chronic Inflammatory Diseases & Beyond 2:30 pm
INF904 – C5aR inhibitor with best-in-class potential C5aR inhibition in Hidradenitis Suppurativa C5aR inhibition in Chronic Spontaneous UrticariaRead more
day: Conference Day One